ArticleFrontiers in oncology2021

High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy.

Huikun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.